Hypoxia-Driven Immune Escape in the Tumor Microenvironment

por Vito, Alyssa, El-Sayes, Nader, Mossman, Karen
Publicado 2020

Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy

por El-Sayes, Nader, Vito, Alyssa, Mossman, Karen
Publicado 2021

Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells

por Farrukh, Hadia, El-Sayes, Nader, Mossman, Karen
Publicado 2021

Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer

por Vito, Alyssa, El-Sayes, Nader, Salem, Omar, Wan, Yonghong, Mossman, Karen L.
Publicado 2021

Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer

por Vito, Alyssa, Rathmann, Stephanie, Mercanti, Natalie, El-Sayes, Nader, Mossman, Karen, Valliant, John
Publicado 2021

A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner

por El-Sayes, Nader, Vito, Alyssa, Salem, Omar, Workenhe, Samuel Tekeste, Wan, Yonghong, Mossman, Karen
Publicado 2022

IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity

por El-Sayes, Nader, Walsh, Scott, Vito, Alyssa, Reihani, Amir, Ask, Kjetil, Wan, Yonghong, Mossman, Karen
Publicado 2022

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells

por Davola, Maria Eugenia, Cormier, Olga, Vito, Alyssa, El-Sayes, Nader, Collins, Susan, Salem, Omar, Revill, Spencer, Ask, Kjetil, Wan, Yonghong, Mossman, Karen
Publicado 2023

Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells

por Vito, Alyssa, Salem, Omar, El-Sayes, Nader, MacFawn, Ian P., Portillo, Ana L., Milne, Katy, Harrington, Danielle, Ashkar, Ali A., Wan, Yonghong, Workenhe, Samuel T., Nelson, Brad H., Bruno, Tullia C., Mossman, Karen L.
Publicado 2021

De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors

por Workenhe, Samuel T., Nguyen, Andrew, Bakhshinyan, David, Wei, Jiarun, Hare, David N., MacNeill, Kelly L., Wan, Yonghong, Oberst, Andrew, Bramson, Jonathan L., Nasir, Jalees A., Vito, Alyssa, El-Sayes, Nader, Singh, Sheila K., McArthur, Andrew G., Mossman, Karen L.
Publicado 2020

Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies

por Fergusson, Dean A., Wesch, Neil L., Leung, Garvin J., MacNeil, Jenna L., Conic, Isidora, Presseau, Justin, Cobey, Kelly D., Diallo, Jean-Simon, Auer, Rebecca, Kimmelman, Jonathan, Kekre, Natasha, El-Sayes, Nader, Krishnan, Ramya, Keller, Brian A., Ilkow, Carolina, Lalu, Manoj M.
Publicado 2019

First-in-class small molecule potentiators of cancer virotherapy

por Dornan, Mark H., Krishnan, Ramya, Macklin, Andrew M., Selman, Mohammed, El Sayes, Nader, Son, Hwan Hee, Davis, Colin, Chen, Andrew, Keillor, Kerkeslin, Le, Penny J., Moi, Christina, Ou, Paula, Pardin, Christophe, Canez, Carlos R., Le Boeuf, Fabrice, Bell, John C., Smith, Jeffrey C., Diallo, Jean-Simon, Boddy, Christopher N.
Publicado 2016

Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses

por Banerjee, Arinjay, El-Sayes, Nader, Budylowski, Patrick, Jacob, Rajesh Abraham, Richard, Daniel, Maan, Hassaan, Aguiar, Jennifer A., Demian, Wael L., Baid, Kaushal, D'Agostino, Michael R., Ang, Jann Catherine, Murdza, Tetyana, Tremblay, Benjamin J.-M., Afkhami, Sam, Karimzadeh, Mehran, Irving, Aaron T., Yip, Lily, Ostrowski, Mario, Hirota, Jeremy A., Kozak, Robert, Capellini, Terence D., Miller, Matthew S., Wang, Bo, Mubareka, Samira, McGeer, Allison J., McArthur, Andrew G., Doxey, Andrew C., Mossman, Karen
Publicado 2021